17-beta-hydroxysteroid dehydrogenase deficiency physical examination
|
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17-beta-hydroxysteroid dehydrogenase deficiency physical examination On the Web |
|
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency physical examination |
|
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency physical examination |
|
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency physical examination |
|
17-beta-hydroxysteroid dehydrogenase deficiency physical examination in the news |
|
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency physical examination |
|
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Majority of affected babies with 17-beta hydroxysteroid dehydrogenase 3 deficiency are born with external genitalia that appear female. In few cases, the external genitalia are ambiguous genitalia. Some other affected infants have male predominant external genitalia, with small penis micropenis or hypospadias. During puberty, the affected individuals develop some male secondary sex characteristics, such as increased muscle mass, deepening of the voice, and development of male pattern facial and body hair and gynecomastia.[1]